M 1798 Ancitabine |
|
| (2,2'-Anydrocytidine, HCl; β-D-2,2'-O-Cyclocytidine, HCl) | |
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC UV chromatogram | |
| Solid | |
| Screw cap v-vial | Please Inquire for Pricing |
| M.W. 261.7 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1822 Ancitabine, [3H]- |
|
| (2,2'-Anydrocytidine, HCl, [3H]-; β-D-2,2'-O-Cyclocytidine, HCl, [3H]-) | |
| MORpure™ HPLC Purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 261.7 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |